What were some of your most satisfying successes of the past year, and why? Advising on the J&J spin-off, which was transformative for our client. Many large pharma players are spinning off their consumer health businesses, and we’ve established ourselves as go-to advisors in this space. In addition to advising J&J, we’ve advised GSK and Merck on their spin-offs.

Also advising Nielsen on its sale. Nielsen has been broken apart and put together multiple times over the course of its history and it has been rewarding to have been part of two transformational projects in my career.